|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Cash flows from operating activities | ||
| Net loss | ||
| Net income/(loss) | ||
| Adjustments to reconcile net income/(loss) to net cash provided by operating activities | ||
| Depreciation and amortization | ||
| Stock-based compensation | ||
| Provision for bad debt expense | ||
| Loss on extinguishment of debt | ||
| Impairment loss | ||
| Loss on lease termination | ||
| Deferred income taxes | ||
| Amortization of debt discount and issuance costs | ||
| Other | ||
| Changes in: | ||
| Accounts receivable | ||
| Income tax refundable | ||
| Prepaid expenses and other current assets | ||
| Deferred costs | ||
| Other long-term assets | ||
| Accounts payable and accrued expenses | ||
| Deferred revenue | ||
| Operating lease right-of-use assets and lease liabilities | ||
| Other long-term liabilities | ||
| Net cash provided by operating activities | ||
| Cash flows from investing activities | ||
| Purchase of property and equipment and capitalization of internally developed software costs | ||
| Acquisitions, net of cash and cash equivalents acquired | ||
| Purchase of investment securities | ||
| Proceeds from sale of investment securities | ||
| Net cash used in investing activities | ||
| Cash flows from financing activities | ||
| Change in aggregated funds liability | ||
| Proceeds from equity offering, net of underwriting discounts | ||
| Payments of third-party IPO issuance costs | ||
| Repurchase of shares | ||
| Proceeds from exercise of common stock options | ||
| Proceeds from issuance of common stock from employee equity plans | ||
| Proceeds from issuances of debt, net of creditor fees | ||
| Payments on debt | ||
| Third-party fees paid in connection with issuance of new debt | ||
| Finance lease liabilities paid | ||
| Net cash provided by (used in) financing activities | ||
| Increase in cash and cash equivalents during the period | ||
| Increase/(decrease) in cash and cash equivalents during the period | ||
| Cash and cash equivalents and restricted cash–beginning of period | ||
| Cash and cash equivalents and restricted cash–end of period | ||
| Supplemental disclosures of cash flow information | ||
| Interest paid | ||
| Cash taxes paid (refunds received), net | ||
| Non-cash investing and financing activities | ||
| Fixed asset purchases in accounts payable | ||
| Unpaid third-party IPO issuance costs | ||
| Common stock issued in connection to acquisitions (see Note 7) | ||
| Reconciliation of Balance Sheet Cash Accounts to Cash Flow Statement | ||
| Balance sheet | ||
| Cash and cash equivalents | ||
| Restricted cash |
Loading...
